ASX:AGN Argenica Therapeutics (AGN) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Argenica Therapeutics Stock (ASX:AGN) 30 days 90 days 365 days Advanced Chart Get Argenica Therapeutics alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket Capitalization$104.40 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewArgenica Therapeutics Limited engages in the research and development of a neuroprotective therapeutic drug in Australia. Its lead product candidate is ARG-007, a neuroprotective peptide candidate use to protect brain cells and reduce cell death during a stroke and other types of neural injuries. Argenica Therapeutics Limited was incorporated in 2019 and is based in Nedlands, Australia.Read More… Receive AGN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Argenica Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address AGN Stock News HeadlinesArgenica Therapeutics Reports Reduced Losses Amid Increased R&D CostsFebruary 11, 2025 | tipranks.comArgenica Therapeutics Ltd Ordinary Shares AGNJanuary 10, 2024 | morningstar.comTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what could be the biggest wealth opportunity since Bitcoin's early days.May 4, 2025 | Crypto 101 Media (Ad)Here's Why We're Not Too Worried About Argenica Therapeutics' (ASX:AGN) Cash Burn SituationJanuary 9, 2024 | finance.yahoo.comArgenica Therapeutics Limited (AGN.AX)January 5, 2024 | finance.yahoo.comArgenica Therapeutics Insider Ups Holding During YearJanuary 5, 2024 | finance.yahoo.comArgenica Therapeutics (ASX:AGN) Is In A Good Position To Deliver On Growth PlansJuly 13, 2022 | finance.yahoo.comWe Think Argenica Therapeutics (ASX:AGN) Can Afford To Drive Business GrowthJuly 13, 2022 | finance.yahoo.comSee More Headlines Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Biotechnology Sub-IndustryInsurance Current SymbolASX:AGN CIKN/A Webargenica.com.au Phone61 8 9329 3396FaxN/AEmployees22,300Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)A($0.06) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-5,480,000.00 Net Margins-238.05% Pretax MarginN/A Return on Equity-60.20% Return on Assets-27.35% Debt Debt-to-Equity RatioN/A Current Ratio6.75 Quick Ratio12.21 Sales & Book Value Annual Sales$2.60 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book ValueA$0.13 per share Price / BookN/AMiscellaneous Outstanding Shares128,090,000Free FloatN/AMarket Cap$104.40 million OptionableNot Optionable Beta0.79 These 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (ASX:AGN) was last updated on 5/4/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredWill May start the next "Great Depression?"You probably haven't heard about this yet... But this could be the biggest wealth building opportunity of t...Behind the Markets | SponsoredWhy Elon put $51 million into thisWhile fear dominates the headlines, a silent breakthrough could turn panic into profit. The future of AI fa...True Market Insiders | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Argenica Therapeutics Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Argenica Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.